EUSEBIO RUBIO-AURIOLES, M.D., Ph.D. obtained his M.D. at Universidad La Salle in Mexico City (1978) México D.F., and his Ph.D. in the Program of Human Sexuality at New York University. (1988) He completed the post-doctoral training course in sex therapy at the Department of Psychiatry of the Mount Sinai Hospital of New York City (1983).Since 1984 he is professor at the Departamento de Psiquiatría y Salud Mental de la Facultad de Medicina de la Universidad Nacional Autónoma de México.In 1987 he founded the Asociación Mexicana para la Salud Sexual, A.C. where he is the director. Since 1993 has completed 22 clinical trials for the development of drugs for the treatment of sexual dysfunction in males and females. He has published several articles in national and international journals and books, he was the Editor of the Antología de la Sexualidad Humana published by the Consejo Nacional de Población. From 1995 to 1998 he served as the first president of the Federación Mexicana de Educación Sexual y Sexología, A.C. He is currently the President of the World Association for Sexual Health (formerly World Association for Sexology)

Professor Kevan Wylie is Consultant at the The Porterbrook Clinic, Sheffield and the Directorate of Urology, Royal Hallamshire Hospital. He is Honorary Senior Clinical Lecturer in Psychiatry and Honorary Clinical Lecturer in Urology, University of Sheffield and Adjunct Associate Professor, University of Sydney. He is also Lead consultant and Clinical Director for Gender Dysphoria Service, Sheffield and Clinical lead for Porterbrook Clinic and Lead clinician RHH Andrology Service.

Dr Wylie holds membership of numerous scientific societies and has held positions on many National and International Scientific committees and Editorial Boards relating to sexual health. He is currently Chairman of the British Society for Sexual Medicine (2007- 2009), President of the International Scientific Committee, World Association for Sexual Health (2005-2009), General Secretary and Treasurer, European Federation of Sexology (2002-2010) and Chairman of Psychosexual Scientific Sub-committee, European Society for Sexual Medicine (2003-2008). He was previously President of Section of Sexuality and Sexual Health, Royal Society of Medicine, London (2005-2007) and Chairman of British Society of Psychosomatic Obstetrics, Gynaecology and Andrology (2005-2007).

He is Fellow of the Royal College of Physicians of London (FRCP) and the Royal College of Psychiatrists (FRCPsych) and Associate Member of the British Association of Urological Surgeons (BAUS) and Royal College of Obstetricians and Gynaecologists (RCOG).

CHRIS G McMAHON is a Consultant Sexual Health Physician and Fellow of the Royal Australian College of Physician’s Chapter of Sexual Medicine. He is an Associate Professor in the Faculty of Health Sciences, University of Sydney and the Director of the Australian Centre for Sexual Health in Sydney, Australia. Dr McMahon is a committee chairman for the WHO Second Consultation on Erectile and Sexual Dysfunction and a chairman of the International Society of Sexual Medicine (ISSM) medical and research standards committee. He is a member of the editorial board of the Journal of Sexual Medicine, International Journal of Sexual Health, Current Sexual Health Reports and the Journal of Men’s Health and an associate section editor of the British Journal of Urology. He is a referee for the Journal of Urology, Urology, European Journal of Urology, the Medical Journal of Australia, the Journal of Sexual Medicine, the British Journal of Urology and Expert Opinion on Investigational Drugs. He is a member of several local, regional and international medical associations and a committee member of the International Society of Sexual Medicine (ISSM). He has been invited to lecture on sexual medicine worldwide and has published extensively on sexual health. He has published over 50 original research and invited review articles in peer reviewed international medical journals, and 10 book chapters. His recent research has focused on drug treatment for patients with refractory erectile dysfunction (ED) and drug treatment of premature ejaculation.